Wednesday, October 7, 2026

Dollar Index Falls 10.8% as Euro Surges 14% in Major Currency Rebalancing

The US Dollar Index dropped 10.8% in early 2025 while the Euro gained 14% and the British Pound advanced 7%, marking a significant currency rebalancing ahead of Federal Reserve leadership transition. The pound traded at $1.3086 in late November after falling 0.5% against the dollar. Analysts are monitoring GBP/USD support levels around $1.30 as dollar weakness persists despite modest recovery attempts.

LM Salvado
LM Salvado

March 21, 2026

Dollar Index Falls 10.8% as Euro Surges 14% in Major Currency Rebalancing
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The US Dollar Index fell 10.8% in the first half of 2025 as major currencies staged a broad rally against the greenback.1 The Euro gained 14% during the period while the British Pound advanced 7%, reflecting a global currency rebalancing amid Federal Reserve transition uncertainty.1

The pound traded at $1.3086 in late November, down 0.5% on the day.1 Currency traders are closely watching the $1.30 level for GBP/USD, a key technical support that could determine near-term direction.30 if dollar weakness reverses.2

Dollar weakness coincides with Jerome Powell preparing to step down as Federal Reserve chair, creating uncertainty around future monetary policy direction.1 The Bank of Canada held rates steady during this period, joining other central banks in maintaining cautious stances as currency volatility increases.1

Simon Phillips, Managing Director at No1 Currency, noted the pound remains under pressure despite its year-to-date gains.13 against the euro in November, hitting its lowest level since April 2023.EUR/USD benefited most from the 14% euro appreciation, while GBP/USD's 7% gain reflects both dollar weakness and UK-specific factors including fiscal policy concerns.1

The currency rebalancing reflects shifting expectations for Federal Reserve policy as Powell's tenure ends. Traders are positioning for potential policy changes under new leadership, contributing to dollar weakness despite recent modest recovery attempts.1

Technical analysts note the dollar index has stabilized after its initial 10.8% drop, but the recovery remains fragile.1 Currency volatility is expected to persist as markets digest Fed transition developments and central bank policy divergence across major economies.

The forex market is pricing in continued uncertainty around US monetary policy direction, keeping pressure on the dollar across major pairs while creating trading opportunities for those monitoring key technical levels.1

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· March 18, 2026
    Fed meeting live updates: Federal Reserve expected to hold rates steady, share outlook amid Iran oil shock
  3. [3]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  4. [4]News articleYahoo Finance· March 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq rise for second day in a row with Fed decision on deck

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,351 source documents archived
Query this data → isubstrate.com